Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AE.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.516EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.526EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.279EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.214EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.284EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.3 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.318EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
R.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ML.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.283EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.96EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.338EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.20.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.562EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.219EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used